Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor

Infectious Disease in Obstetrics and Gynecology

Volumn 12, Issue 2, 2004, Pages 69-78

  Wegner, Carole C ^a   Jordan, Jeanne A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

B19; Globoside; Placenta; Trophoblast

Indexed keywords

GLOBOSIDE; GLOBOSIDE RECEPTOR; IMMUNOGLOBULIN M ANTIBODY; IODINE 125; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOTINYLATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LINEAR SYSTEM; NONHUMAN; PARVOVIRUS; PLACENTA VILLUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TROPHOBLAST; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS STRAIN; VIRUS TRANSMISSION;

BINDING, COMPETITIVE; BIOTINYLATION; CAPSID; FEMALE; GLOBOSIDES; HUMANS; IMMUNOGLOBULIN M; IODINE RADIOISOTOPES; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TROPHOBLASTS;

EID: 10944268267     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440400009912     Document Type: Article

References (39)

1. Agbandje M, Kajigaya S, McKenna R, Young NS, Rossmann MG. The structure of human parvovirus B19 at 8Å resolution. Virology 1994;203:106-15
2. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-6
3. Berry PJ, Gray ES, Porter HJ, Burton PA. Parvovirus infection of the human fetus and newborn. Semin Diag Pathol 1992;9:4-12
4. C receptors in the human placenta: transport or immune surveillance. J Anat 1994;184:297-308
5. Brown KE, Cohen BJ. Haemagglutination by parvovirus B19. J Gen Virol 1992;73:2147-9
6. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-17
7. Brown KE, Hibbs JR, Gallinelli G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-6
8. Caulín C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-94
9. Chipman PR, Agbandje-McKenna M, Kajgaya S, et al. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci USA 1996;93:75026
10. Chisaka J, Morita E, Murata K, et al. A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19. J Gen Virol 2002;83:273-81
11. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995;172:1198-205
12. Cossart YE, Cant B, Field AM, Widdows D. Parvovirus-like particles in human sera. Lancet 1975;i:72-3
13. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by prokaryotic expression of isolated genomic fragments. J Virol 1986;60:548-57
14. Cotmore SF, Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science 1984;226:1161-5
15. Damsky CH, Fisher SJ. Trophoblast pseudovasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol 1998;10:660-6
16. Douglas GC, King BF. Isolation of pure villous cytotrophoblasts from term placenta using immunomagnetic microspheres. J Immunol Methods 1989;119(2):259-68
17. 131I-labeled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-23
18. Jordan JA. Identification of human parvovirus B19 infection in idiopathic non-immune hydrops fetalis. Am J Obstet Gynecol 1995;174:37-42
19. Jordan JA, Butchko AR. Apoptotic activity in villous trophoblast cells during human parvovirus B19 infection correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Placenta 2002;23:547-52
20. Jordan JA, DeLoia JA. Globoside expression within the human placenta. Placenta 1999;20:103-8
21. Kaydrov M, Kaufmann K, Huppertz B. Expression of a cytokeratin 18-neoepitope is a specific marker for trophoblast apoptosis in human placenta. Placenta 2001;22:44-8.
22. Kertschanska S, Kosanke G, Kaufmann P. Is there morphologic evidence for the existence of transtrophoblastic channels in human placental villi? Trophoblast Reearch 1994;8:581-96
23. Kliman HJ, Nestler JE, Sermasi E, Sanger JM. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placenta. Endocrinology 1986;118:1567-82
24. Lindton B, Tolfvenstam T, Norbeck O, et al. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro. Fetal Diagn Ther 2001;16:26-31
25. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998;72:3018-28
26. Morey AL, Ferguson DJ, Fleming KA. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro. J Pathol 1993;169:213-20
27. 2 phase with accumulation of mitotic cyclins. J Virol 2001;75:7555-63
28. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 1983;302:426-9
29. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young NS. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988;61:2395(406
30. Palmer ME, Watson AL, Burton GJ. Morphological analysis of degeneration and regeneration of syncytiotrophoblast in first trimester villi during organ culture. Hum Reprod 1997;12:379-82
31. Serke S, Schwarz TF, Baurman H, et al. Productive infection of in vitro generated haemapoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. Br J Haematol 1991;79:6-13
32. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during plastic crisis. J Virol 1986;58:921-36
33. Shimomura S, Komatsu N, Frickhofen N, Anderson S, Kajigaya S, Young NS. First continuous propagation of B19 parvovirus in a cell line. Blood 1992;79(1):18-24
34. Srivastava CH, Zhou S, Munshi NC, Srivastava A. Parvovirus B19 replication in human umbilical cord blood cells. Virology 1992;189:456-61
35. Takahashi T, Ozawa K, Takahashi K, Asano S, Takaku F. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 1990;75:603-10
36. von dem Borne AEGKr, Bos MJE, Joustras-Maas N, Tromp JF, van Wijngaarden-du Bois R, Tetteroo PAT. A murine monoclonal IgM antibody specific for blood group P antigen. Br J Haematol 1986;63:35-46
37. Weigel-Kelley KA, Yoder C, Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001;75:4110-16
38. Yaegashi N, Niinuma T, Chisaka H, et al. Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. J Infect Dis 1999;39:68-76
39. Zipursky A. The erythrocytes of the newborn infant. Semin Haematol 1965;2:167